Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent.

[1]  M. Tonelli,et al.  CHAPTER 3 , 2006, Journal of the American Society of Nephrology.

[2]  R. Gosens,et al.  Functional characterization of serum‐ and growth factor‐induced phenotypic changes in intact bovine tracheal smooth muscle , 2002, British journal of pharmacology.

[3]  Kazuyoshi Watanabe,et al.  Effect of Intranasal Administration of CV-11974, a Type 1 Angiotensin II Receptor Antagonist, on Airway Hyperresponsiveness and Airway Inflammation Induced by Antigen Inhalation in Guinea Pigs , 2002, International Archives of Allergy and Immunology.

[4]  B. Graham,et al.  Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor , 2002, Thorax.

[5]  A. Takeshita,et al.  Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.

[6]  A. Takeshita,et al.  Possible Involvement of Rho-Kinase in the Pathogenesis of Hypertension in Humans , 2001, Hypertension.

[7]  K. Kaibuchi,et al.  Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF , 2001, The Journal of cell biology.

[8]  T. Katagiri,et al.  Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation , 2001, Journal of hypertension.

[9]  S. Eguchi,et al.  Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase , 2000, Regulatory Peptides.

[10]  S. Hirst,et al.  Airway smooth muscle as a target in asthma. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  A. Bayés‐Genís,et al.  The insulin-like growth factor axis: A review of atherosclerosis and restenosis. , 2000, Circulation research.

[12]  S. Miyamoto,et al.  Augmented acetylcholine‐induced, Rho‐mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen‐induced airway hyperresponsive rats , 1999, British journal of pharmacology.

[13]  P. Cohen,et al.  Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle. , 1999, American journal of respiratory cell and molecular biology.

[14]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[15]  S. Johnson,et al.  Synthetic functions of airway smooth muscle in asthma. , 1997, Trends in pharmacological sciences.

[16]  Y. Nasuhara,et al.  Mechanisms of epidermal growth factor-induced contraction of guinea pig airways. , 1996, European journal of pharmacology.

[17]  N. Thomson,et al.  Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. , 1995, The European respiratory journal.

[18]  M. Kelleher,et al.  Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. , 1995, The American journal of physiology.

[19]  N. Thomson,et al.  Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. , 1994, Thorax.

[20]  R. Alexander,et al.  Vasoactive effects of growth factors. , 1989, Biochemical pharmacology.

[21]  R. Alexander,et al.  Vasoconstriction: a new activity for platelet-derived growth factor. , 1986, Science.

[22]  R. Gosens,et al.  Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype. , 2004, European journal of pharmacology.

[23]  K. Kaibuchi,et al.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. , 2001, Trends in pharmacological sciences.

[24]  J. D. de Jongste,et al.  Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. , 1998, American journal of respiratory cell and molecular biology.